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Abstract: Pyrroline-5-carboxylate reductase 1 (PYCR1) catalyzes the last step in proline synthesis.
Deficiency of PYCR1, caused by a defect in PYCR1, was recently described in patients with cutis laxa,
intrauterine growth retardation, developmental dysplasia of the hips and mental retardation. In this
paper, we describe additional six patients (ages ranging from 4 months to 55 years) from four Iranian
families with clinical manifestations of a wrinkly skin disorder. All patients have distinct facial features
comprising triangular face, loss of adipose tissue and thin pointed nose. Additional features are short
stature, wrinkling over dorsum of hand and feet, visible veins over the chest and hyperextensible joints.
Three of the patients from a large consanguineous family do not have mental retardation, while the
remaining three patients from three unrelated families have mental and developmental delay. Mutation
analysis revealed the presence of disease-causing variants in PYCR1, including a novel deletion of the
entire PYCR1 gene in one family, and in each of the other patients the homozygous missense mutations
c.616G > A (p.Gly206Arg), c.89T > A (p.Ile30Lys) and c.572G > A (p.Gly191Glu) respectively, the latter
two of which are novel. Light- and electron microscopy investigations of skin biopsies showed smaller
and fragmented elastic fibres, abnormal morphology of the mitochondria and their cristae, and slightly
abnormal collagen fibril diameters with irregular outline and variable size. In conclusion, this study adds
information on the natural course of PYCR1 deficiency and sheds light on the pathophysiology of this
disorder. However, the exact pathogenesis of this new disorder and the role of proline in the development
of the clinical phenotype remain to be fully explained.
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Abstract Pyrroline-5-carboxylate reductase 1 (PYCR1)
catalyzes the last step in proline synthesis. Deficiency of
PYCR1, caused by a defect in PYCR1, was recently
described in patients with cutis laxa, intrauterine growth
retardation, developmental dysplasia of the hips and mental
retardation. In this paper, we describe additional six patients
(ages ranging from 4 months to 55 years) from four Iranian
families with clinical manifestations of a wrinkly skin
disorder. All patients have distinct facial features compris-
ing triangular face, loss of adipose tissue and thin pointed
nose. Additional features are short stature, wrinkling over
dorsum of hand and feet, visible veins over the chest and
hyperextensible joints. Three of the patients from a large
consanguineous family do not have mental retardation,
while the remaining three patients from three unrelated
families have mental and developmental delay. Mutation
analysis revealed the presence of disease-causing variants
in PYCR1, including a novel deletion of the entire PYCR1
gene in one family, and in each of the other patients the
homozygous missense mutations c.616G>A (p.Gly206Arg),
c.89T>A (p.Ile30Lys) and c.572G>A (p.Gly191Glu)
respectively, the latter two of which are novel. Light- and
electron microscopy investigations of skin biopsies showed
smaller and fragmented elastic fibres, abnormal morphology
of the mitochondria and their cristae, and slightly abnormal
collagen fibril diameters with irregular outline and variable
size. In conclusion, this study adds information on the
natural course of PYCR1 deficiency and sheds light on the
pathophysiology of this disorder. However, the exact
pathogenesis of this new disorder and the role of proline in
the development of the clinical phenotype remain to be fully
explained.
Introduction
The term cutis laxa refers to a heterogeneous group of skin
disorders characterised by loose and inelastic skin that can
be either inherited or acquired. In inherited forms, the
defect arises mostly from the synthesis and/or assembly of
abnormal elastic fibres, whereas acquired forms result from
destruction of normal elastic fibres. Inherited forms of cutis
laxa are characterised by generalised cutaneous laxity
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which is present at birth or develops soon after. Other
organs such as the lungs, aorta, gastrointestinal tract and
genitourinary system are generally involved. The classifi-
cation of the inherited forms of cutis laxa comprises
different categories based on the mode of inheritance
(Table 1).
In the autosomal dominant group (MIM #123700), skin
laxity can already be present at birth or can be late in
onset, and the disorder can be caused by mutations in the
elastin gene, ELN (MIM *130160) (Morava et al. 2009;
Tassabehji et al. 1998) or in FBLN5 (MIM *604580)
(Markova et al. 2003). The X-linked recessive form, also
known as occipital horn syndrome (MIM #304150), which
is allelic to Menkes disease (MIM #309400), is due to
mutations in a copper-transporting ATPase encoded by
ATP7A (MIM *300011) (Kaler et al. 1994). The third and
most heterogeneous category is defined by an autosomal
recessive mode of inheritance and comprises two types.
Type I (MIM #219100) is associated with early pulmonary
emphysema, poor prognosis and can be caused by
missense mutations in FBLN4 (also known as EFEMP2;
MIM *604633) and FBLN5 (MIM *604580) (Hucthagowder
et al. 2006; Loeys et al. 2002). Autosomal recessive cutis
laxa type II (ARCL2; MIM #219200) is sometimes referred
to as cutis laxa with growth and developmental delay or as
cutis laxa with joint laxity and retarded development.
Related disorders, the group of so-called wrinkly skin
disorders, include gerodermia osteodysplastica (GO) or Walt
Disney dwarfism (MIM #231070) and the wrinkly skin
syndrome (WSS; MIM #278250).
Definitive criteria for distinguishing these conditions
unambiguously are lacking, leaving a subjective element in
clinical diagnosis. Thus, molecular diagnosis is proving
increasingly useful in resolving these phenotypically
similar disorders.
In individuals with cutis laxa type II, mutations have
been identified in two genes, specifically H(+)-ATPase V0
subunit A2 encoded byATP6V0A2 (MIM *611716; classified
as cutis laxa type IIA) (Kornak et al. 2008) and SCYL1
binding protein encoded by SCYL1BP1 (MIM *607983)
(Hennies et al. 2008).
Mutations have also been found in a member of the
aldehyde dehydrogenase family, namely ALDH18A1 (alias
delta1-pyrroline-5-carboxylate synthetase, P5CS; MIM
*138250); this gene was found to be defective in patients
described with a so-called neurocutaneous syndrome closely
resembling cutis laxa type II (Baumgartner et al. 2000, 2005;
Bicknell et al. 2008). Remarkably, this condition (MIM
*612652) is associated with metabolic changes suggestive of
an inborn error of metabolism, in particular resembling
findings of a urea cycle defect (hypoprolinemia, hypoorni-
thinemia, hypocitrullinemia, hypoargininemia and hyper-
ammonemia). P5CS is a bifunctional ATP- and NADPH-
dependent mitochondrial enzyme which catalyses the reduc-
tion of glutamate to delta1-pyrroline-5-carboxylate (P5C), a
critical step in the biosynthesis of proline, ornithine and
arginine (Phang et al. 2001). P5C is the immediate precursor
for both proline and ornithine, reactions catalysed by
pyrroline-5-carboxylate reductase (P5CR, encoded by
PYCR1; MIM *179035; classified as cutis laxa type IIB)
and ornithine aminotransferase (encoded by OAT; MIM
*613349), respectively (Phang et al. 2001). The biochemical
pathway of P5CS and P5CR is depicted in Fig. 1.
Recently, mutations in PYCR1 were described in patients
with a phenotypic spectrum comprising wrinkly skin,
osteopenia and progeroid appearance with or without
mental retardation (Guernsey et al. 2009; Reversade et al.
2009). The pathophysiological basis appears to be an
impaired mitochondrial function leading to developmental
defects through increased apoptosis.
Table 1 Differential diagnosis of cutis laxa disorders
Cutis laxa disorders and syndromes
Autosomal dominant: defect in ELN or FBLN5; present at birth or late-onset skin laxity, no mental retardation
X-linked: occipital horn syndrome; defect in ATP7A; copper deficiency; mild mental retardation
Autosomal recessive:
Type I: defect in FBLN4 and FBLN5; early pulmonary emphysema, some with mental retardation
Type II: defect in ATP6VOA2; caused by abnormal N- and O-glycosylation; with mental retardation
Δ1-Pyrroline-5-carboxylate synthetase: defect in ALDH18A1; low proline, citrulline, arginine, ornithine; mental retardation (but only two
families described)
Pyrroline-5-carboxylate reductase: defect in PYCR1; normal amino acids; some with normal mental development
Gerodermia osteodysplastica: defect in GORAB (previous symbol: SCYL1BP1); precocious skin aging and osseous changes, no mental
retardation
Costello syndrome: defect in HRAS; facio-cutaneo-skeletal syndrome; mental retardation
De Barsy syndrome: defect unknown; with corneal clouding and mental retardation; ATP6V0A2-CDG in some patients
Cantu syndrome: defect unknown; with osteochondrodysplasia and cardiac anomalies; some with mild mental retardation
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In this paper, we describe an additional six patients with
clinical manifestations of a wrinkly skin disorder in whom
disease-causing variants in PYCR1 were found. The paper
focuses in particular on light- and electron microscopy
investigations which showed alterations in collagen and
elastic fibres.
Materials and methods
Patients
Patient 1 is the first and only child of related Iranian
parents. After an uneventful pregnancy, she was born at
term by caesarean section due to breech presentation. Birth
weight was 1,600 g (<3rd centile), but length and head
circumference were not documented. She presented with
developmental dysplasia of the hip. Examination at 5 years
of age showed a normal cognitive development but mild
facial dysmorphism with triangular face, deep set eyes,
pinched nose, low-set ears, high arched palate and small
teeth. She had wrinkled, thin and translucent skin with
visible veins. Additional signs were pectus excavatum;
hypermobility of finger, wrist, elbow, knee and toe joints;
pes planus; hallux valgus; talipes equinovarus and general-
ised muscle weakness. Patient 1 was referred with a
suspicion of a type of Ehlers-Danlos syndrome.
Patient 2 is a 49-year-old male and a relative of patient 1.
There is not much information regarding pregnancy.
Delivery was by normal vaginal delivery at term. We do
not have exact measurements, but relatives claim that the
infant was very small, both in weight and length. Head
circumference was apparently normal. Milestones were
delayed, but cognition was normal as was puberty. He
was examined at 49 years. His measurements were as
follows: weight 45 kg (<3rd centile for Iranian population),
height 150 cm (<3rd centile) and head circumference 51 cm
(<3rd centile). He had thin wrinkled face, loss of adipose
tissue in face and limbs, pinched nose, prominent chin,
widely spaced teeth and wrinkling of dorsum of hands and
feet (Fig. 2). He had recurrent dislocation of his right
shoulder, pes planus and hyperextensibility of joints,
especially in hands and feet, which has improved over
time. He has myopia. The patient is married and has two
healthy children. Radiography of chest shows osteopenic
rib bones.
Patient 3 is a 54-year-old female and the sister of patient
2. Information regarding pregnancy and infancy is not
available. Delivery was at term by normal vaginal delivery,
and although we do not have measurements at birth, the
relatives claim that she weighed less and was much shorter
than normal healthy infants. She had delayed milestones.
She had normal puberty with menses starting at 15 years
and menopause at 52 years. She was examined at 54 years.
Her height, weight and head circumference were 145 cm
(<3rd centile for Iranian population), 40 kg (<3rd centile)
and 49 cm (<3rd centile), respectively. She had a thin long
face, thin pinched nose, prominent chin and loss of adipose
tissue in her face (Fig. 2). The hands and feet are very small
with wrinkling on the dorsum. Pes planus is evident. The
skin is thin and loose. Cognition is normal. She never
married.
Patient 4 is the first and only child of first cousin Iranian
parents. He was born spontaneously at 36 weeks of gestation,
after an uneventful pregnancy. Birth weight was 2,000 g (3rd
centile), length 42 cm (3rd centile) and head circumference
34 cm (<50th centile). At follow up at 5 years, the patient
presented a thin, translucent, lax and wrinkly skin as well as
hypermobile joints with developmental dysplasia of the
hip and pes planus. Clinically, he showed distinct facial
features with hollow cheeks, pinched nose, loss of
adipose tissue, prominent low-set simple ears and thin
lips. There were neither blue sclerae nor atrophic scars.
Gross motor developmental milestones were delayed: he
could sit at 12 months and walk unsupported at 2 years.
His cognitive development was also delayed, and he
could speak only a few words at 5 years of age. Figure 3
shows the phenotype of patient 4 at age 5 years.
Patient 5 was spontaneously born at term after an
uneventful pregnancy as the second child of a consanguin-
eous Iranian family. The parents and their first child were
healthy. Birth weight was 2,300 g (<3rd centile), length
47 cm (3rd centile), and head circumference 33 cm (<50th
centile). Thriving was regular, but he presented mild motor
and mental retardation. Developmental dysplasia of the hip
was present, and the skin was lax and wrinkled with
prominent vessels over the chest and abdomen. In addition,
he showed joint laxity, long fingers, pes planus, delayed
bone age, osteoporosis and mild facial dysmorphism with a
Fig. 1 Pathway of proline biosynthesis and its connection to the
human urea cycle. P5C Δ1-Pyrroline-5-carboxylate, OAT ornithine
aminotransferase, GAA guanidinoacetate, CP creatine phosphate
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triangular face, arched eyebrows, and prominent simple
ears. He had dental caries, strabismus and myopia and
needed an operation for his right undescended testis when
he was 7 years old. Plasma ammonia and concentrations of
plasma amino acids were normal. This patient was referred
with a suspicion of wrinkly skin syndrome. Figure 4 shows
the clinical presentation of the patient at 1 and 8 years.
Patient 6 is the first and only child of first cousin parents.
Sonography revealed severe oligohydramnios. Delivery
was by normal vaginal delivery at 9 months. Birth weight
and length were 1,400 g (<3rd centile) and 35 cm (3rd
centile) respectively. At 9 months, weight was 4.5 kg (<3rd
centile), height was 62 cm (<3rd centile) and head
circumference was 39 cm (<3rd centile).He had a pinched
nose, deep set eyes, blue sclera, cleft palate, pectus
excavatum, hyperextensibility of fingers and wrists, prom-
inent vessels (mostly on abdomen and chest), muscle
weakness, developmental dysplasia of the hip, poor
feeding, wrinkling over dorsum of hands and feet and
muscle weakness.The child was developmentally delayed,
showed head control at 9 months, could sit with support at
16 months but has not developed the ability to stand nor
started saying single words. Ophthalmologic examination
revealed blue sclera and mild myopic astigmatism. X-rays
taken at 9 months showed developmental dysplasia of the
hip, knee joint subluxation, wormian bones in the skull and
decreased bone density.
The main clinical signs of all patients are summarised in
Table 2.
Mutation analysis
Genomic DNA was isolated from peripheral blood cells by
standard methods. The ALDH18A1 gene was PCR ampli-
fied for each of the 17 coding exons including flanking
intronic regions. Annealing temperatures were 60°C for exons
2–11 and 13–16, 62°C for exons 12 and 18, and 54°C for exon
17. Likewise, PCR was performed for the PYCR1 gene
amplifying all eight coding exons including flanking regions.
Annealing temperatures were 58°C for exon 1, 62°C for
exons 2–7, and 64°C for exon 8. Primer sequences can be
obtained from the authors on request. PCR products were
directly sequenced using the 3130xI Genetic Analyzer
(Applied Biosystems, Life Technologies).
Fig. 2 Facial appearance of
patients 2 (a) and 3 (b, c) at age
45 and 50 years, respectively.
Note the facial similarities to the
young patients (as shown in
Figs. 3 and 4)
Fig. 3 Clinical phenotype of
patient 4 at age 5 years. Note the
facial dysmorphism with
triangular face, pinched nose,
thin lips and the lax, wrinkly
translucent skin with visible
veins
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Genetic investigations were performed after written
informed consent of the parents was obtained.
MLPA analysis
Three self-designed MLPA probes specific for exons 4, 5,
and 8 of the PYCR1 gene were used with a commercially
available set of control probes (MLPA kit P300, MRC,
Holland). The MLPA analysis was performed using DNA
of patients 1, 2 and 3 as well as from other family members
according to the standard method recommended by MRC
Holland. Separation of the products was performed by
capillary electrophoresis on a 310 Genetic Analyzer
(Applied Biosystems).
Light and electron microscopy of skin
A portion of the skin biopsy from patients 1 and 5, taken to
establish fibroblast cultures, was processed for light and
transmission electron microscopy. For light microscopy,
semi-thin sections (1 μm) were stained with methylene
blue. Electron microscopy was performed as previously
reported (Vogel et al. 1979). The biopsy site was the lateral
upper thigh region.
Biochemical analysis of collagens
Cultured dermal fibroblasts were established from a
skin biopsy obtained from patient 5. Cells were
maintained under standard conditions and radiolabeled
as previously described (Steinmann et al. 1984). At the
end of the incubation, medium and cell layer were
harvested separately, and collagen samples were prepared
by digestion with pepsin, precipitated with ethanol,
separated on a 5% SDS-PAGE and visualised by
fluorography (Steinmann et al. 1984).
Results
Mutation analysis
In all patients from this study, two mutant alleles in PYCR1
were identified.
In patient 1, we did not succeed in amplifying any of the
PYCR1 exons. The suspected occurrence of a novel
homozygous deletion in the index-patient was confirmed
by MLPA using three probes specific for PYCR1. The
MLPA analysis also revealed the homozygous loss of the
Fig. 4 Clinical phenotype of patient 5 at age 1 (a) and 8 (b) years. Note the facial dysmorphism with progeroid features at age 1 year (a) and the
translucent skin with visible veins (b)
Patient IUGR Thin, translucent,
lax, wrinkly skin
Developmental
dysplasia of
the hip
Pes
planus
Facial
dysmorphism
Mental
retardation
Delayed
motor
development
1 + + + + + - +
2 + + - + + - +
3 + + - + + - +
4 + + + + + + +
5 + + + + + + +
6 + + + ? + + +
Table 2 Main clinical signs in
the patients of this study
? Not known
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PYCR1 gene in the fourth-degree cousins (patients 2 and 3),
while all obligate heterozygous parents as well as additional
family members were found to be carriers of this mutant
allele (Fig. 5). The analysis of the neighbouring genes
MAFG and MYADML2 showed normal results in all family
members, indicating that the deletion affects only the
PYCR1 gene (data not shown).
In patient 4, investigation of the ALDH18A1 gene did
not reveal any mutations. However, in PYCR1 a previously
described homozygous missense mutation c.616G>A
(p.Gly206Arg) in exon 5 was found; both parents were
carriers of this change (Reversade et al. 2009). The
residue Gly206 lies within a highly conserved region of
the PYCR1 gene that is conserved in mammals.
DNA sequencing of all coding exons including the
flanking regions of the PYCR1 gene for patient 5
revealed a single novel homozygous missense mutation
c.89T>A (p.Ile30Lys) in exon 2. The residue Ile30 is
conserved in mouse, rat, dog, cattle and anopheles but not
in chimpanzee.
In patient 6, the novel mutation c.572G>A (p.Gly191Glu)
in exon 5 of the PYCR1 gene was identified in a homozygous
state with both parents being carriers for this mutation. The
residue Gly191 lies within a highly conserved region of the
PYCR1 gene that is conserved in mammals, drosophila and
anopheles.
Light and electron microscopy of skin
Light microscopy of a skin biopsy of patient 5 showed,
distributed between collagen bundles, elastic fibres which
were abnormally thin and which showed “jagged” contours.
Overall, there was a reduction in elastic material and
decrease in elastic fibre size when compared to a normal
control sample (Fig. 6a, b).
Ultrastructural analysis of a skin biopsy of patient 5
revealed abnormally thin elastic fibres, and slightly abnor-
mal collagen fibrils with irregular contours and variable
sized diameters. Furthermore, the morphology of mito-
chondria and their cristae was altered (Fig. 6c, d; control
shown in Fig. 6e, f).
Likewise, morphological analysis of a skin biopsy of
patient 1 disclosed a reduced amount of elastic material
(decreased size and fragmentation of elastic fibres).
Ultrastructurally, the elastin component was surrounded
by excessive elastic microfibrils. Collagen bundles, espe-
cially those adjacent to elastic fibres, were less compact and
revealed variation in single fibril calibers.
Biochemical analysis of collagens
Radiolabelled collagens retained by cultured dermal fibro-
blasts and secreted into the culture medium were separated
and treated with pepsin and subjected to SDS-PAGE and
fluorography. In patient 5, we detected normal migration
patterns for collagens I, III and V in both the medium and
the cell layer (not shown).
Discussion
Although wrinkled and lax skin is an “inevitable conse-
quence of normal human aging” (Kornak 2009), it is also a
striking clinical presentation in patients with P5CR defi-
ciency. The presentation of lax and wrinkled skin in a child
often leads to the suspicion of Ehlers-Danlos syndrome,
biochemically characterised by collagen abnormalities.
However, lax and wrinkled skin rather point towards
abnormalities of elastic fibres and their synthesis. This
entity has been recently reviewed highlighting also a few
metabolic disorders which can present with wrinkled skin
or cutis laxa (Morava et al. 2009). As cutis laxa disorders
overlap considerably, proper diagnosis is challenging.
All six patients presented in this study were referred to
our centre for further work-up of a wrinkly skin syndrome.
Based on clinical findings, in particular developmental
delay, we considered the still short list of metabolic
disorders presenting with cutis laxa.
In patient 1, MLPA analysis revealed the presence of a
genomic deletion comprising the entire PYCR1 gene with
two further relatives also affected (patients 2 and 3 of this
study) and obligate heterozygotes in the family found to be
carriers of this deletion (Fig. 5). It is interesting that all
patients from family 1 were the only ones in this study not
affected by mental retardation although they all had a
homozygous deletion of PYCR1.
Fig. 5 Pedigree of family 1 indicating patients 1, 2 and 3 as well as
obligate heterozygotes investigated in this study
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In patient 4, P5CS deficiency was investigated first but
no mutation was found. Because of the considerable
clinical overlap among the known disorders of proline
biosynthesis, genetic investigation of the PYCR1 gene was
also performed and revealed the presence of a homozygous
mutation within a highly conserved domain of PYCR1, with
both parents being carriers. The same genotype was
previously reported in a patient from the same ethnic
background (Reversade et al. 2009).
Because of the phenotypic similarity to patient 4, PYCR1
mutation analysis was done in patient 5 and revealed the
novel missense mutation c.89T>A (p.Ile30Lys) in a homo-
zygous state. Since no other mutation was found within the
PYCR1 gene and because of the high grade of conservation
across species, this mutation was considered likely to be
responsible for the clinical phenotype of the patient.
In patient 6, the novel mutation c.572G>A (p.Gly191Glu)
in exon 5 of the PYCR1 gene was found affecting a residue
which is highly conserved across species.
The assumption of a disease-causing role of the PYCR1
mutations we detected was further supported by the results
of light and electron microscopy. In patients 1 and 5, EM of
a skin biopsy showed fragmentation, rarefaction and size
reduction of the elastic fibres, as previously shown in P5CR
deficiency (Reversade et al. 2009). Furthermore, it revealed
mild alterations of the collagen bundles, mostly of those
proximal to elastic fibres.
The pathophysiological mechanism underlying P5CR
deficiency is still far from clear, but several observations
suggest a role of P5CR in the cell’s response to oxidative
stress. Ultrastructural analysis of mitochondrial morphology
in cultured fibroblasts revealed abnormal morphology of
mitochondria and their cristae (Reversade et al. 2009),
which was similarly found in our patients.
As depicted in Fig. 1 the enzyme proline oxidase (POX;
also known as proline dehydrogenase, PRODH) catalyses
the rate-limiting two-electron oxidation of proline to P5C. It
has been suggested that the intracellular accumulation of
proline is an adaptive stress response that affords oxidative
stress protection in mammalian cells because overexpres-
sion of P5CS and P5CR observed after exposing cell lines
to physiological H2O2 levels resulted in two-fold higher
proline content, lower ROS levels and increased cell
survival (Krishnan et al. 2008). Furthermore, lower expres-
sion of ornithine aminotransferase (OAT) was measured
during H2O2 stress, indicating that the P5C-ornithine
pathway was suppressed in order to funnel the P5C
intermediate to proline synthesis (Krishnan et al. 2008).
The recent observation that a defect in GLUT10-
mediated transport of L-dehydroascorbic acid (DHA) is
Fig. 6 Light and electron microscopy analysis in patient 5. a, b Semi-
thin section, methylene blue staining. a Control: regular distribution of
collagen bundles (light blue) and elastic fibres (dark blue). b Patient 5:
fibres are small, thin and fragmented, so that the overall amount of
elastic material is reduced; the number of elastic fibres is not
substantially reduced. c–f Ultra-thin sections (magnification 8,800x).
c Altered mitochondria (M). d Small fragmented elastic fibres within
reticular dermis with marginal elastic microfibrils. e Normal female
control aged 42 years. Elastic fibres (E) and collagen bundles (C) are
shown; note that elastic fibres are larger and thicker in size than in the
patients (c, d). f Normal female control aged 42 years: a dermal
fibroblast [within normal collagen (C) bundles] is shown; in the
cytoplasm ER cisterns (ER) and mitochondria (M) are depicted. An
elastic fibre is shown only partially (E)
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the pathophysiological mechanism underlying arterial tor-
tuosity syndrome (Lee et al. 2010) might also shed light on
the pathomechanism of P5CR deficiency. Parallels can be
drawn between the protective mechanism against oxidative
damage operating in vascular smooth muscle cells by
mitochondrial GLUT10 transport of DHA and the protec-
tive mechanism operating in fibroblasts through the
mitochondrial proline synthesis pathway. Thus, it can be
hypothesized that enhanced transcription and activation of
matrix metalloproteinases (MMPs) and, as a consequence
of increased ROS, enhanced degradation of the extracellu-
lar matrix as shown in vascular smooth muscle cells (Satoh
et al. 2009), may also occur in the tissues most severely
affected by P5CR deficiency. This mechanism might
account for the rarefaction and fractionation of elastic
fibres as documented in the skin biopsies of P5CR-deficient
patients.
The clinical picture of P5CR deficiency with progeroid
appearance during infancy might be the result of apoptosis
due to compromised mitochondrial function during prenatal
development. In addition, the physiologically high activity
of OAT during early infancy (Raiha and Kekomaki 1968)
might result in low levels of P5C and proline because OAT
serves to produce ornithine rather than proline and P5C in
this period in life. When OAT works mostly in the other
direction (i.e. to produce P5C from ornithine) later in life, the
degree of P5C and proline drainage might be decreasing.
However, in contrast to P5CS deficiency where some
patients have low proline, P5CR-deficient patients seem to
have normal serum proline levels (Reversade et al. 2009).
Unfortunately, we could only perform two single amino
acid profiles in two of the patients of this study; the results
were normal.
Clinically, the combination of progeroid appearance,
wrinkled skin, developmental dysplasia of the hip, IUGR
and neuromotor developmental delay should suggest the
diagnosis of P5CR deficiency. EM of a skin biopsy might
be a helpful diagnostic tool, in particular to distinguish
P5CR from P5CS deficiency; however, since many of the
cutis laxa syndromes are monogenetic disorders, mutation
analysis may be warranted.
Acknowledgements The authors would like to thank the families
for their consent for publication of photos.
References
Baumgartner MR, Hu CA, Almashanu S, Steel G, Obie C, Aral B,
Rabier D, Kamoun P, Saudubray JM, Valle D (2000) Hyper-
ammonemia with reduced ornithine, citrulline, arginine and
proline: a new inborn error caused by a mutation in the gene
encoding delta(1)-pyrroline-5-carboxylate synthase. Hum Mol
Genet 9:2853–2858
Baumgartner MR, Rabier D, Nassogne MC, Dufier JL, Padovani JP,
Kamoun P, Valle D, Saudubray JM (2005) Delta1-pyrroline-5-
carboxylate synthase deficiency: neurodegeneration, cataracts
and connective tissue manifestations combined with hyper-
ammonaemia and reduced ornithine, citrulline, arginine and
proline. Eur J Pediatr 164:31–36
Bicknell LS, Pitt J, Aftimos S, Ramadas R, Maw MA, Robertson SP
(2008) A missense mutation in ALDH18A1, encoding delta1-
pyrroline-5-carboxylate synthase (P5CS), causes an autosomal
recessive neurocutaneous syndrome. Eur J Hum Genet 16:1176–
1186
Guernsey DL, Jiang H, Evans SC, Ferguson M, Matsuoka M,
Nightingale M, Rideout AL, Provost S, Bedard K, Orr A, Dube
MP, Ludman M, Samuels ME (2009) Mutation in pyrroline-5-
carboxylate reductase 1 gene in families with cutis laxa type 2.
Am J Hum Genet 85:120–129
Hennies HC, Kornak U, Zhang H, Egerer J, Zhang X, Seifert W,
Kuhnisch J, Budde B, Natebus M, Brancati F, Wilcox WR,
Muller D, Kaplan PB, Rajab A, Zampino G, Fodale V,
Dallapiccola B, Newman W, Metcalfe K, Clayton-Smith J,
Tassabehji M, Steinmann B, Barr FA, Nurnberg P, Wieacker P,
Mundlos S (2008) Gerodermia osteodysplastica is caused by
mutations in SCYL1BP1, a Rab-6 interacting golgin. Nat Genet
40:1410–1412
Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY,
Urban Z (2006) Fibulin-4: a novel gene for an autosomal
recessive cutis laxa syndrome. Am J Hum Genet 78:1075–1080
Kaler SG, Gallo LK, Proud VK, Percy AK, Mark Y, Segal NA,
Goldstein DS, Holmes CS, Gahl WA (1994) Occipital horn
syndrome and a mild Menkes phenotype associated with splice
site mutations at the MNK locus. Nat Genet 8:195–202
Kornak U (2009) Lessons from cutis laxa syndromes: wrinkles due to
improper reloading of the extracellular matrix? Eur J Hum Genet
17:1097–1098
Kornak U, Reynders E, Dimopoulou A, van Reeuwijk J, Fischer B,
Rajab A, Budde B, Nurnberg P, Foulquier F, Lefeber D, Urban Z,
Gruenewald S, Annaert W, Brunner HG, van Bokhoven H,
Wevers R, Morava E, Matthijs G, Van Maldergem L, Mundlos S
(2008) Impaired glycosylation and cutis laxa caused by mutations
in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet
40:32–34
Krishnan N, Dickman MB, Becker DF (2008) Proline modulates the
intracellular redox environment and protects mammalian cells
against oxidative stress. Free Radic Biol Med 44:671–681
Lee YC, Huang HY, Chang CJ, Cheng CH, Chen YT (2010)
Mitochondrial GLUT10 facilitates dehydroascorbic acid import
and protects cells against oxidative stress: mechanistic insight
into arterial tortuosity syndrome. Hum Mol Genet 19:3721–3733
Loeys B, Van Maldergem L, Mortier G, Coucke P, Gerniers S,
Naeyaert JM, De Paepe A (2002) Homozygosity for a missense
mutation in fibulin-5 (FBLN5) results in a severe form of cutis
laxa. Hum Mol Genet 11:2113–2118
Markova D, Zou Y, Ringpfeil F, Sasaki T, Kostka G, Timpl R, Uitto J,
Chu ML (2003) Genetic heterogeneity of cutis laxa: a heterozy-
gous tandem duplication within the fibulin-5 (FBLN5) gene. Am
J Hum Genet 72:998–1004
Morava E, Guillard M, Lefeber DJ, Wevers RA (2009) Autosomal
recessive cutis laxa syndrome revisited. Eur J Hum Genet
17:1099–1110
Phang JM, Hu CA, Valle D (2001) Disorders of proline and
hydroxyproline metabolism. In: Scriver C, Beaudet A, Sly W,
Valle D (eds) The metabolic and molecular bases of inherited
disease, 8th edn. McGraw-Hill, New York, pp 1821–1838
Raiha NC, Kekomaki MP (1968) Studies on the development of
ornithine-keto acid aminotransferase activity in rat liver. Biochem
J 108:521–525
738 J Inherit Metab Dis (2011) 34:731–739
Reversade B, Escande-Beillard N, Dimopoulou A, Fischer B, Chng
SC, Li Y, Shboul M, Tham PY, Kayserili H, Al-Gazali L,
Shahwan M, Brancati F, Lee H, O'Connor BD, Schmidt-von
Kegler M, Merriman B, Nelson SF, Masri A, Alkazaleh F,
Guerra D, Ferrari P, Nanda A, Rajab A, Markie D, Gray M,
Nelson J, Grix A, Sommer A, Savarirayan R, Janecke AR,
Steichen E, Sillence D, Hausser I, Budde B, Nurnberg G,
Nurnberg P, Seemann P, Kunkel D, Zambruno G, Dallapiccola
B, Schuelke M, Robertson S, Hamamy H, Wollnik B, Van
Maldergem L, Mundlos S, Kornak U (2009) Mutations in
PYCR1 cause cutis laxa with progeroid features. Nat Genet
41:1016–1021
Satoh K, Nigro P, Matoba T, O'Dell MR, Cui Z, Shi X, Mohan A, Yan
C, Abe J, Illig KA, Berk BC (2009) Cyclophilin A enhances
vascular oxidative stress and the development of angiotensin II-
induced aortic aneurysms. Nat Med 15:649–656
Steinmann B, Rao VH, Vogel A, Bruckner P, Gitzelmann R, Byers PH
(1984) Cysteine in the triple-helical domain of one allelic product
of the alpha 1(I) gene of type I collagen produces a lethal form of
osteogenesis imperfecta. J Biol Chem 259:11129–11138
Tassabehji M, Metcalfe K, Hurst J, Ashcroft GS, Kielty C, Wilmot C,
Donnai D, Read AP, Jones CJ (1998) An elastin gene mutation
producing abnormal tropoelastin and abnormal elastic fibres in a
patient with autosomal dominant cutis laxa. Hum Mol Genet
7:1021–1028
Vogel A, Holbrook KA, Steinmann B, Gitzelmann R, Byers PH
(1979) Abnormal collagen fibril structure in the gravis form (type I)
of Ehlers-Danlos syndrome. Lab Invest 40:201–206
J Inherit Metab Dis (2011) 34:731–739 739
